Auxogyn Inc. believes it has found a way to increase the success rate of in vitro fertilization procedures. Its new, noninvasive imaging technology is designed to provide novel data regarding the viability of an embryo, and using time-lapse imaging, will allow embryologists to determine which embryos have the highest likelihood of developing into blastocytes and result in a health pregnancy.
Increasing the odds in IVF
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Bristol’s CEO Christopher Boerner says business development is the company’s biggest spending priority as analysts raise concerns about growth, citing a need for BMS to do more deals.
Sales of the company’s approved cancer therapies were weaker or down, but Trodelvy is likely to see a label expansion and cell therapies are making progress.
CEO Robert Michael said AbbVie is positioned strongly to handle current and potentially upcoming tariffs, while committing $10bn to increased US manufacturing sites.
